Page last updated: 2024-08-26

mafosfamide and Multiple Myeloma

mafosfamide has been researched along with Multiple Myeloma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reich, S; Sidi, H; Slavin, G; Slavin, S; Weiss, L1
Barnett, MJ; Brockington, DA; Klingemann, HG; Nantel, SH; Phillips, GL; Reece, DE; Shepherd, JD; Sutherland, HJ1

Trials

1 trial(s) available for mafosfamide and Multiple Myeloma

ArticleYear
Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma.
    Bone marrow transplantation, 2000, Volume: 26, Issue:6

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Humans; Interferon-alpha; Male; Middle Aged; Multiple Myeloma; Treatment Outcome; Vincristine

2000

Other Studies

1 other study(ies) available for mafosfamide and Multiple Myeloma

ArticleYear
Successful purging of murine plasmacytoma by mafosfamide (ASTA-Z).
    Bone marrow transplantation, 1994, Volume: 13, Issue:1

    Topics: Animals; Antineoplastic Agents; Bone Marrow Purging; Cyclophosphamide; Disease Models, Animal; Humans; Mice; Mice, Inbred BALB C; Multiple Myeloma; Plasmacytoma; Transplantation, Autologous

1994